跳至主要内容
临床试验/NCT06048978
NCT06048978已完成不适用

The Effect of Starch Processing on Postprandial Blood Glucose in Humans

INQUIS Clinical Research2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
Postprandial Glycemia

研究概览

简要总结

The goal of this clinical trial is to determine the postprandial glycemic response of the two starches in humans. Participants will be asked to consume 2 test foods on 2 separate occasions and provide blood glucose samples over 120 minutes postprandial.

详细描述

Enrolled participants who are generally healthy and free of major chronic conditions will be randomized to receive either Commercial Native Starch or Extrusion Processed Starch first and then will be crossed over to receive the opposite Intervention. The study will consist of two clinical test visits of 120 minutes separated by a washout period of at least 24 hours.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult males or non-pregnant females.
  • eligible to receive income in Canada.

排除标准

  • age less than 18 years
  • any known food allergies or intolerances to the investigational product
  • medications known to affect glucose tolerance -but stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable
  • known history of diabetes mellitus or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related conditions
  • any major medical or surgical events requiring hospitalization within the preceding 3 months
  • the presence of disease or drug(s) which influence digestion and absorption of nutrients
  • the short-term use of systemic steroids or atypical antipsychotics (<4 weeks) (all of which have major effects on glucose and metabolism and body fat distribution)
  • any other medications or conditions which might, in the opinion of the Medical Director of INQUIS Clinical Research Ltd. (INQUIS), either 1) make participation dangerous to the subject or to others, or 2) affect the results
  • any subject who cannot or will not comply with the experimental procedures or do not follow INQUIS safety guidelines

结局指标

主要结局

Postprandial Glycemia

时间窗: -5 to 120 minutes after intervention administration

Incremental area under the curve for blood glucose over 120 minutes.

次要结局

  • Incremental Blood Glucose(0, 15, 30, 45, 60, 90, and 120 minutes after intervention administration)

研究者

发起方
INQUIS Clinical Research
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Blood Glucose Response of Processed Starch | 临床试验